netFormulary Dorset NHS
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Looking for Alemtuzumab found 4 matches

Formulary BNF Category
  Cytotoxic Drug Restricted Drug  Alemtuzumab  (Lemtrada) Anti-lymphocyte monoclonal antibodies - 08.02.03
  Alemtuzumab  (Lemtrada)
(Multiple Sclerosis)
Multiple Sclerosis - 08.02.04

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Clinical Commissioning Policy 170075P: Alemtuzumab for treating relapsing-remitting multiple sclerosis third cycle (all ages) (08.02.04)
link in drug section NICE TA312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis (08.02.04)